Filing Details
- Accession Number:
- 0001127602-12-023284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-31 20:00:42
- Reporting Period:
- 2012-07-27
- Filing Date:
- 2012-07-31
- Accepted Time:
- 2012-07-31 20:00:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1145154 | J David Scott | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Svp, Gen. Counsel & Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-07-27 | 30,000 | $82.00 | 65,558 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-07-30 | 1,391 | $71.88 | 66,949 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-30 | 42,109 | $71.88 | 109,058 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-30 | 20,000 | $42.13 | 129,058 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-30 | 30,000 | $50.44 | 159,058 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-30 | 20,000 | $58.43 | 179,058 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-30 | 1,391 | $84.29 | 177,667 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-30 | 42,109 | $84.25 | 135,558 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-30 | 20,000 | $84.23 | 115,558 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-30 | 30,000 | $83.95 | 85,558 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-30 | 20,000 | $83.93 | 65,558 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Iso (Right to Buy) | Disposition | 2012-07-30 | 1,391 | $0.00 | 1,391 | $71.88 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-07-30 | 42,109 | $0.00 | 42,109 | $71.88 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-07-30 | 20,000 | $0.00 | 20,000 | $42.13 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-07-30 | 30,000 | $0.00 | 30,000 | $50.44 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-07-30 | 20,000 | $0.00 | 20,000 | $58.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-04-03 | 2013-04-03 | No | 4 | M | Direct |
| 0 | 2007-04-03 | 2013-04-03 | No | 4 | M | Direct |
| 0 | 2009-04-29 | 2015-04-29 | No | 4 | M | Direct |
| 10,000 | 2010-04-28 | 2016-04-28 | No | 4 | M | Direct |
| 20,000 | 2011-04-26 | 2020-04-26 | No | 4 | M | Direct |
Footnotes
- The price reported is an average price. The prices ranged from $84.28 to $84.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- The price reported is an average price. The prices ranged from $84.23 to $84.28 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- The price reported is an average price. The prices ranged from $84.22 to $84.26 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- The price reported is an average price. The prices ranged from $83.90 to $84.03 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- The price reported is an average price. The prices ranged from $83.90 to $83.97 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; and 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- These shares include 31 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Billionaire Hedge Funds
